These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 5955829

  • 21. [Multiple pseudocystic tuberculosis of the bone due to BCG vaccination--with special reference to bacteriological investigation].
    Fujiwara M.
    Kobe Daigaku Igakubu Kiyo; 1970 Mar; 32(1):170-210. PubMed ID: 5535702
    [No Abstract] [Full Text] [Related]

  • 22. [Stability and immunogenicity of the fresh BCG vaccine applied with a new multiple puncture device (author's transl)].
    Gheorghiu M, Lagranderie M, Bredèche M.
    Ann Microbiol (Paris); 1981 Mar; 132(3):307-18. PubMed ID: 7027870
    [Abstract] [Full Text] [Related]

  • 23. Tuberculin sensitivity and morphological immune response in guinea pigs after application of minimal sensitizing dose of BCG vaccine, substrain Sofia SL222.
    Bachvarova M, Stefanova T, Nikolaeva S, Chouchkova M.
    Int Immunopharmacol; 2009 Jul; 9(7-8):1010-5. PubMed ID: 19393344
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Association of hepatitis B vaccine with other vaccines--laboratory animals study.
    Mazert MC, Chabanier G, Adamowicz P, Gerfaux G.
    Dev Biol Stand; 1983 Jul; 54():53-62. PubMed ID: 6228476
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T, Lasco TM, Uchida K, Goto Y, Jeevan A, McFarland C, Ly L, Yamamoto S, McMurray DN.
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [Abstract] [Full Text] [Related]

  • 31. [Examination of protein MPB 70 properties in BCG substrains used for the production of Polish antituberculosis vaccines].
    Janaszek W, Wysokińska T, Aleksandrowicz J.
    Med Dosw Mikrobiol; 1998 Mar; 50(1-2):47-54. PubMed ID: 9857613
    [Abstract] [Full Text] [Related]

  • 32. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.
    Murphy D, Corner LA, Gormley E.
    Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731
    [Abstract] [Full Text] [Related]

  • 33. [Dynamics of the immunomorphological changes occurring in the reticulohistiocytic system of the liver during BCG vaccination in guinea pigs].
    Diaconitza G, Ionesco J.
    Arch Roum Pathol Exp Microbiol; 1968 Mar; 27(1):5-16. PubMed ID: 5706451
    [No Abstract] [Full Text] [Related]

  • 34. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.
    Basaraba RJ, Izzo AA, Brandt L, Orme IM.
    Vaccine; 2006 Jan 16; 24(3):280-6. PubMed ID: 16153758
    [Abstract] [Full Text] [Related]

  • 35. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct 16; 67(4):863-9. PubMed ID: 6944553
    [Abstract] [Full Text] [Related]

  • 36. [History of anti-tuberculosis vaccination and the development of BCG vaccine].
    Moskwa Z.
    Wiad Lek; 1983 Jan 01; 36(1):81-5. PubMed ID: 6342271
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
    Kita Y, Tanaka T, Yoshida S, Ohara N, Kaneda Y, Kuwayama S, Muraki Y, Kanamaru N, Hashimoto S, Takai H, Okada C, Fukunaga Y, Sakaguchi Y, Furukawa I, Yamada K, Inoue Y, Takemoto Y, Naito M, Yamada T, Matsumoto M, McMurray DN, Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Skeiky Y, Reed S, Sakatani M, Okada M.
    Vaccine; 2005 Mar 18; 23(17-18):2132-5. PubMed ID: 15755583
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.